Clinical TrialsSearch results
Number of results: 68479
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2008-06-26
Not yet recruiting
- WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical study
- rhabdomyosarcoma
- Osaka university graduate school of medicine Pediatrics
- 2014-03-04
Other
- WT1 peptide-based cancer vaccine for long-term maintenance of anti-tumor immunity
- solid tumor, malignant lymphoma, acute leukemia
- Osaka University Graduate Shool of Medicine, Functional Diagnostic Science
- 2014-12-20
Other
- WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical study
- Pancreatic cancer
- Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine
- 2011-04-01
Other
- WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene"
- Acute myelogeous lekemia, Myelodysplastic syndrome
- Mie University Graduate School of Medicine
- 2015-05-06
Other
- WT1 peptide vaccination for pediatric patients: phase I/II study.
- pediatric malignant tumor, hematological malignancy
- Osaka University Graduate School of Medicine
- 2014-02-25
Other
- WT1 peptide vaccination for patinets with hematological CR after induction chemotherapy
- Cancer vaccine
- Cancer immunotherapy of Osaka University
- 2015-06-17
No Longer Recruiting
- WT1 peptide pulse dendritic cells vaccine therapy for pancreatic cancer following resection
- Pancreatic cancer
- Yanagisawa Ryu
- 2019-10-01
Other
- WT1 based chemoimmunotherapy
- advanced pancreatic cancer
- Koido Shigeo
- 2020-01-28
Other
- WS-01 long-term observational study
- patients, treated with WS-01 stent for recurrent stroke attributable to intracranial atherosclerotic disease, refractory to medical treatment, in intracranial vessels.
- Kobe City Hospital Organization General Hospital Nobuyuki Sakai
- 2010-03-09